Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1009 of 5804
-
Skin cells could help heal torn shoulder tendons
Disease control Recruiting nowThe goal of this study is to evaluate the efficacy and safety of allogeneic dermal fibroblasts (TPX-115) compared to placebo in patients with Partial-Thickness Rotator Cuff Tear(PTRCT). Primary endpoint is to evaluate the efficacy of TPX-115 compared to placebo, as measured by i…
Phase: PHASE2 • Sponsor: Tego Science, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New cocktail of four drugs targets tough sarcomas in kids
Disease control Recruiting nowThe goal of this study is to build on the experience of the SAINT trial by evaluating the safety and efficacy of the addition of pazopanib to their published chemotherapy regimen.
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New obesity drug trial aims for 25% weight loss with gentler dosing
Disease control Recruiting nowThe purpose of the study is to find out if NNC0662-0419 is safe and effective for treating participants living with obesity.
Phase: PHASE2 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Could a scan replace surgery for breast cancer staging?
Diagnosis Recruiting nowStudy hypothesis is that combining the advantages of hybrid PET/MRI and the high sensitivity/specificity of 16-alpha-18F-fluoro-17-beta-estradiol(FES), a radiolabeled form of estrogen binding to functionally active ER, the investigators could obtain a reliable, non-invasive, oper…
Phase: PHASE2 • Sponsor: Università Vita-Salute San Raffaele • Aim: Diagnosis
Last updated Jun 27, 2026 13:06 UTC
-
New drug aims to stop kidney transplant rejection
Disease control Recruiting nowThe goal of the global Phase 1/2 clinical trial is to evaluate whether CID-103, a novel anti-CD38 monoclonal antibody, is safe and effective in adults with with active and chronic active renal allograft antibody mediated rejection (ABMR). The main questions the study aims to answ…
Phase: PHASE1, PHASE2 • Sponsor: CASI pharmaceuticals, Inc. • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Could a single day of TMS plus a pill ease suicidal thoughts in BPD?
Symptom relief Recruiting nowThis study tests a new treatment for people with borderline personality disorder (BPD). The treatment combines a medication called D-cycloserine with one day of transcranial magnetic stimulation (TMS). The main questions it aims to answer are: * How many participants complete t…
Phase: PHASE1, PHASE2 • Sponsor: Mclean Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
New pill aims to ease fatigue in rare mitochondrial disease
Disease control Not yet recruitingThe purpose of this study is to investigate if the study medicine, KL1333, is safe, well-tolerated and effective long-term in improving the symptoms of fatigue and impacts on daily living and functional capacity (physical abilities) in people with PMD.
Phase: PHASE2 • Sponsor: Pharming Technologies B.V. • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New PET tracer could sharpen prostate cancer detection
Diagnosis Recruiting nowPrimary Objective: To evaluate the safety and tolerability of PET imaging following a single intravenous infusion of \[⁶⁸Ga\]Ga-ELI421 injection in patients with prostate cancer. Secondary Objectives: To evaluate the biodistribution characteristics of \[⁶⁸Ga\]Ga-ELI421 injecti…
Phase: PHASE1, PHASE2 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Diagnosis
Last updated Jul 10, 2026 00:00 UTC
-
New study targets ovarian cancer in black women: could genes affect treatment?
Disease control Recruiting nowThe purpose of this study is to identify the genetic characteristic(s), specifically degree of African ancestry, and environmental characteristic(s) that appear to be related to the effects, both good and bad, that the maintenance treatment has women with ovarian cancer. In this …
Phase: PHASE4 • Sponsor: University of Miami • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Morning vs. afternoon: can timing boost cancer immunotherapy?
Disease control Recruiting nowThis phase IV trial is evaluating whether morning versus afternoon administration of standard of care immunotherapy impacts its effectiveness in treating patients with solid tumors that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of…
Phase: PHASE4 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Could a cholesterol drug help Kids' hearts after kawasaki disease?
Disease control Recruiting nowThe goal of this observational study is to learn about the safety and effects of atorvastatin in treatment of Chinese Kawasaki disease (KD) children complicated with coronary artery abnormalities (CAA) in acute phase. The main questions it aims to answer are: Is atorvastatin safe…
Phase: PHASE3 • Sponsor: Children's Hospital of Fudan University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Lifeline for cancer patients: rollover study extends access to targeted drug opnurasib
Disease control Recruiting nowThe purpose of this study is to allow continued access to opnurasib (JDQ443) to participants who are benefitting from treatment with opnurasib as a single agent or in combination with other study treatments in pre-defined Novartis-sponsored opnurasib studies and to continue to as…
Phase: PHASE1, PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
AI-Crafted diet supplement takes on type 2 diabetes
Disease control Recruiting nowAIM-MET is a randomized clinical study testing whether a fixed microbiome-targeted nutritional product can improve blood sugar control in adults with type 2 diabetes when used in addition to usual stable diabetes treatment. The study will compare the active nutritional product w…
Phase: NA • Sponsor: ENBIOSIS BIOTECHNOLOGIES • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New antibody cocktail aims to tame ulcerative colitis for good
Disease control ENROLLING_BY_INVITATIONThis is a multicenter, long-term extension (LTE) study in participants with ulcerative colitis (UC) from Study SPY123-201 (The SKYLINE-UC study).
Phase: PHASE2 • Sponsor: Spyre Therapeutics, Inc. • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New trial tests gentler surgery for ovarian cysts to save fertility
Disease control Not yet recruitingEndometriosis is a benign, chronic, and often recurrent gynecological disease affecting approximately 10% of women of reproductive age. Among the different manifestations of the disease, ovarian endometrioma represents one of the most common forms, occurring in up to 50% of affec…
Phase: NA • Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New drug may keep rare lymphoma at bay after first treatment
Disease control Recruiting nowThis phase II trial tests how well duvelisib works as treatment that is given to help keep cancer from coming back after it has disappeared following the initial therapy (maintenance) for patients with peripheral T-cell lymphomas. Duvelisib is in a class of medications called kin…
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug combo aims to control advanced breast cancer
Disease control Not yet recruitingThe goal of this clinical trial is to evaluate the safety, tolerability, and efficacy of AK138D1 as monotherapy or in combination with ivonescimab in patients with advanced breast cancer. Participants will receive study treatment with AK138D1 alone or in combination with ivonesc…
Phase: PHASE1, PHASE2 • Sponsor: Akeso • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Could zapping nerves in lung arteries ease pressure after heart valve surgery?
Disease control Recruiting nowthis study aims to investigate the efficacy and safety of PADN therapy compared with standard medical therapy in patients diagnosed with pulmonary hypertension after M-TEER, thereby providing evidence for clinical treatment decision-making
Phase: EARLY_PHASE1 • Sponsor: Xiamen Cardiovascular Hospital, Xiamen University • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New contact lenses aim to stop kids from becoming nearsighted
Prevention Recruiting nowThis study will evaluate the effect of dual focus contact lenses on Myopia prevention.
Phase: NA • Sponsor: CooperVision International Limited (CVIL) • Aim: Prevention
Last updated Jul 18, 2026 00:00 UTC
-
New growth hormone treatment for short children enters final testing phase
Disease control Recruiting nowThis study aims to evaluate the efficacy and safety of GB06 (a biosimilar of Norditropin®FlexProTM from Novo Nordisk) for the treatment of growth disorders caused by growth hormone deficiency (GHD) in children. It aims to determine whether the annual height velocity (an index of…
Phase: PHASE3 • Sponsor: Kexing Biopharm Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC